Stock Analysis on Net
Stock Analysis on Net

Celgene Corp. (NASDAQ:CELG)

This company has been moved to the archive! The financial data has not been updated since October 31, 2019.

Common-Size Income Statement 
Quarterly Data

Celgene Corp., common-size consolidated income statement (quarterly data)

Microsoft Excel
3 months ended: Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015 Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014
Net product sales 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost of goods sold, excluding amortization of acquired intangible assets -3.70 -3.43 -3.48 -4.19 -4.04 -3.31 -3.82 -3.42 -3.59 -3.41 -3.83 -3.81 -3.63 -4.04 -4.24 -4.15 -4.75 -4.47 -5.06 -5.02 -4.99 -5.36 -5.04
Gross profit 96.30% 96.57% 96.52% 95.81% 95.96% 96.69% 96.18% 96.58% 96.41% 96.59% 96.17% 96.19% 96.37% 95.96% 95.76% 95.85% 95.25% 95.53% 94.94% 94.98% 95.01% 94.64% 94.96%
Other revenue 0.04 0.02 0.02 0.02 0.05 0.16 0.20 0.11 0.12 0.37 0.34 0.12 0.48 0.36 0.68 0.95 0.93 1.05 1.25 1.49 1.30 1.52 1.32
Research and development -25.83 -25.01 -30.22 -28.20 -27.79 -32.85 -62.39 -78.70 -41.03 -25.62 -33.71 -38.12 -55.70 -34.57 -29.39 -30.59 -56.41 -49.24 -24.62 -28.46 -34.50 -24.77 -41.80
Selling, general and administrative -17.29 -18.03 -19.21 -21.06 -19.18 -20.75 -24.47 -22.25 -18.52 -28.81 -21.00 -23.00 -23.51 -26.68 -21.77 -23.99 -23.80 -27.36 -25.75 -26.49 -25.43 -26.66 -28.94
Amortization of acquired intangible assets -2.41 -2.48 -2.71 -3.15 -3.26 -3.34 -2.46 -2.27 -2.44 -2.70 -2.78 -3.54 -2.93 -6.37 -3.68 -3.47 -2.75 -2.83 -3.09 -3.10 -3.26 -3.54 -3.85
Acquisition/integration related income (charges) and restructuring, net -0.71 -3.09 -1.91 1.34 -2.60 -0.89 -0.88 40.96 -1.49 0.40 -1.32 -0.42 -0.84 1.31 -1.45 -3.30 -9.78 1.30 -0.92 -1.83 -0.08 -0.05 -0.50
Operating income 50.11% 47.99% 42.50% 44.77% 43.19% 39.02% 6.17% 34.44% 33.05% 40.23% 37.70% 31.24% 13.86% 30.01% 40.15% 35.45% 3.44% 18.45% 41.80% 36.58% 33.04% 41.14% 21.19%
Interest and investment income, net 1.00 0.86 0.84 0.37 0.21 0.24 0.37 0.95 1.01 0.74 0.51 0.30 0.25 0.26 0.27 0.19 0.37 0.39 0.44 0.37 0.35 0.40 0.37
Interest expense -4.21 -4.36 -4.77 -4.71 -4.96 -5.04 -4.70 -4.08 -3.87 -3.87 -4.30 -4.27 -4.31 -4.49 -4.89 -4.91 -3.83 -2.14 -2.39 -2.52 -2.73 -2.26 -1.72
Other income (expense), net -4.47 -3.09 6.51 -12.76 -3.01 0.11 27.33 1.21 0.00 -0.95 0.44 -10.51 -1.15 -0.46 1.41 -1.37 -0.85 4.19 0.40 0.16 -1.15 -0.96 -0.39
Other income and (expense) -7.68% -6.59% 2.58% -17.10% -7.76% -4.70% 23.00% -1.93% -2.86% -4.08% -3.35% -14.48% -5.21% -4.69% -3.20% -6.09% -4.30% 2.44% -1.55% -1.99% -3.53% -2.82% -1.73%
Income (loss) before income taxes 42.43% 41.40% 45.08% 27.68% 35.42% 34.32% 29.17% 32.51% 30.19% 36.15% 34.35% 16.76% 8.65% 25.33% 36.94% 29.36% -0.86% 20.89% 40.24% 34.59% 29.51% 38.32% 19.46%
Income tax provision -5.00 -5.68 -6.68 -1.09 -7.61 -6.88 -5.21 -34.84 -0.09 -2.36 -2.78 -2.35 -2.88 -3.53 -4.85 -7.27 -0.61 -5.08 -5.26 -4.72 -3.53 -5.91 -3.08
Net income (loss) 37.43% 35.71% 38.39% 26.59% 27.81% 27.44% 23.96% -2.33% 30.09% 33.78% 31.57% 14.41% 5.77% 21.80% 32.10% 22.09% -1.47% 15.80% 34.98% 29.87% 25.99% 32.41% 16.38%

Based on: 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-K (reporting date: 2017-12-31), 10-Q (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31), 10-K (reporting date: 2016-12-31), 10-Q (reporting date: 2016-09-30), 10-Q (reporting date: 2016-06-30), 10-Q (reporting date: 2016-03-31), 10-K (reporting date: 2015-12-31), 10-Q (reporting date: 2015-09-30), 10-Q (reporting date: 2015-06-30), 10-Q (reporting date: 2015-03-31), 10-K (reporting date: 2014-12-31), 10-Q (reporting date: 2014-09-30), 10-Q (reporting date: 2014-06-30), 10-Q (reporting date: 2014-03-31).

Income statement item Description The company
Operating income The net result for the period of deducting operating expenses from operating revenues. Celgene Corp. operating income as a percentage of net product sales increased from Q1 2019 to Q2 2019 and from Q2 2019 to Q3 2019.
Income (loss) before income taxes Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Celgene Corp. income (loss) before income taxes as a percentage of net product sales decreased from Q1 2019 to Q2 2019 but then slightly increased from Q2 2019 to Q3 2019.
Net income (loss) The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Celgene Corp. net income (loss) as a percentage of net product sales decreased from Q1 2019 to Q2 2019 but then increased from Q2 2019 to Q3 2019 not reaching Q1 2019 level.